Physician profile
Tal Raizer
NPI 1124473889
$1,098.00
in general payments reported to CMS, 2019-2025
13 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.43 · 2022: $131 · 2023: $173 · 2024: $361 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $256.26 | 2024-2025 | Daxxify, Daxi |
| Neurocrine Biosciences, INC. | $120.49 | 2024-2025 | Ingrezza |
| Abbvie INC. | $116.18 | 2023 | |
| Novo Nordisk INC | $109.22 | 2024 | Wegovy |
| Depuy Synthes Sales INC. | $86.23 | 2022-2024 | Orthovisc |
| Boston Scientific Corporation | $77.79 | 2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.62 | 2023-2024 | Jardiance |
| Eisai INC. | $61.12 | 2024 | |
| Amgen INC. | $52.43 | 2021 | |
| Mylan Specialty L.P. | $50.80 | 2022 | |
| Horizon Therapeutics Plc | $47.19 | 2022 | |
| Exact Sciences Corporation | $40.33 | 2024 | Cologuard Collection Kit |
| Bioventus LLC | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tal Raizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.